Original ArticlesPHOTODYNAMIC THERAPY FOR CHILDHOOD CHOROIDAL NEOVASCULAR MEMBRANE ASSOCIATED WITH BEST’S VITELLIFORM DYSTROPHYRishi, Pukhraj MS, DO; Sharma, Tarun MD, FRCSEd; Gopal, Lingam MS, DNB, FRCSEdAuthor Information From the Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India. Reprints requests: Dr. Pukhraj Rishi, MS, DO, Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, 18, College Road, Chennai, 600006 Tamilnadu, India; e-mail: firstname.lastname@example.org Retinal Cases & Brief Reports: July 2009 - Volume 3 - Issue 3 - p 288-292 doi: 10.1097/ICB.0b013e31817f2df5 Buy Metrics AbstractIn Brief Purpose: Subfoveal choroidal neovascular membrane is an uncommon cause of visual impairment in children and that caused secondary to Best’s disease is a well-known entity. However, limited experience exists in treatment of such lesions in the pediatric age group. This report describes the outcomes of treatment in three such eyes. Methods: Three eyes of two children were treated with Verteporfin photodynamic therapy. One patient was observed up to 23 months and the other for up to 2 years. Results: All three eyes were stabilized with a fair to good visual recovery. No ocular or systemic side effects were noted. Conclusion: Verteporfin photodynamic therapy may be a considered treatment option for childhood choroidal neovascular membranes secondary to Best’s disease. Verteporfin photodynamic therapy may be a considered treatment option for childhood choroidal neovascular membranes secondary to Best’s disease. © 2009 Ophthalmic Communications Society, Inc.